Personalized Medicine & Peptides w/ Dr. John Catanzaro [Ep. 55]

Streamed on:
134

In this episode of Healthy & Awake, I’m joined by Dr. John A. Catanzaro, NMD, PhD, a leader in personalized and integrative medicine and CEO of Neo7 Bioscience. We discuss his journey into naturopathic medicine, the differences between naturopathic and conventional medical training, and the innovative approaches his company is developing to treat complex diseases like cancer and autoimmune disorders. Dr. Catanzaro shares insights on cutting-edge topics such as CRISPR technology, the safety of peptides like BPC 157, and the role of AI in advancing medical research. We also explore the future of personalized medicine, how it's challenging the standard pharmaceutical model, and his vision for addressing health disparities through advanced biotechnology. Tune in for a thought-provoking conversation on how precision-based therapies are transforming healthcare!

https://neo7bioscience.com/
___________________________

🧠 "Innovative Health Strategies" Unleashed: As a Board-Certified Health Coach, I guide you through personalized strategies for optimal health and awareness. Explore more at www.avantiahealthoptimization.com.

👓 Get the stylish BonCharge Glasses I wear—15% off with code 'healthy-and-awake'. https://bit.ly/3ZtPFPv 🛒 https://us.boncharge.com/?rfsn=6048119.41d325&shpxid=d9221375-dc34-4567-b502-708061629285

📚 Books for critical thinkers—Healthy & Awake Book List: https://bit.ly/3PNN7Js

📢 Heads up: The links in the episode's show notes are affiliate links. Making a purchase through these links is a great way to support the show—at no extra cost to you!

Twitter: https://twitter.com/MikeVeraHealth
Facebook: https://www.facebook.com/healthyandawakepodcast
Instagram: https://www.instagram.com/MikeVeraHealth
Youtube: https://www.youtube.com/@healthyandawakepodcast
Rumble: https://rumble.com/c/c-3481244
LinkedIn: https://www.linkedin.com/in/michaelfvera/
TikTok: https://www.tiktok.com/@MikeVeraHealth
Substack: https://mikevera.substack.com/

Loading 2 comments...